Literature DB >> 16156720

Recombinant prion protein does not possess SOD-1 activity.

Samantha Jones1, Mark Batchelor, Daljit Bhelt, Anthony R Clarke, John Collinge, Graham S Jackson.   

Abstract

A considerable body of evidence now shows that PrP (prion protein) binds metal ions with high affinity and it has been claimed that the binding of copper (II) ions to PrP confers SOD (superoxide dismutase) activity. In turn, it has been suggested that PrP is a synaptic dismutase and that loss of this function, as a result of the conversion of PrP(C) into PrP(Sc), results in pathology and hence morbidity associated with prion disease. However, contrary to previous reports, in the present study we have found that PrP exhibits no detectable dismutase activity above baseline levels measured for copper (II) ions in water when assayed using a reliable procedure with a detection limit of at least 2 units of activity/mg of protein. This was true when the assay was performed with either PrP refolded from a denatured state in the presence of copper, as in previous studies, or native PrP loaded with copper. Thus if PrP has any role in oxidative stress, it must be indirect as a regulator of protective cellular responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156720      PMCID: PMC1316266          DOI: 10.1042/BJ20051236

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

Authors:  D R Brown; W J Schulz-Schaeffer; B Schmidt; H A Kretzschmar
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein.

Authors:  C Kurschner; J I Morgan
Journal:  Brain Res Mol Brain Res       Date:  1996-04

3.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

4.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system.

Authors:  C Kurschner; J I Morgan
Journal:  Brain Res Mol Brain Res       Date:  1995-05

6.  Molecular characteristics of the major scrapie prion protein.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Biochemistry       Date:  1984-12-04       Impact factor: 3.162

7.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

8.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

9.  Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol.

Authors:  C Nebot; M Moutet; P Huet; J Z Xu; J C Yadan; J Chaudiere
Journal:  Anal Biochem       Date:  1993-11-01       Impact factor: 3.365

10.  Neurotoxicity of a prion protein fragment.

Authors:  G Forloni; N Angeretti; R Chiesa; E Monzani; M Salmona; O Bugiani; F Tagliavini
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

View more
  15 in total

1.  Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions.

Authors:  Jijun Dong; Jesse D Bloom; Vladimir Goncharov; Madhuri Chattopadhyay; Glenn L Millhauser; David G Lynn; Thomas Scheibel; Susan Lindquist
Journal:  J Biol Chem       Date:  2007-09-24       Impact factor: 5.157

Review 2.  Insights into prion protein function from atomistic simulations.

Authors:  Miroslav Hodak; Jerzy Bernholc
Journal:  Prion       Date:  2010-01-16       Impact factor: 3.931

Review 3.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

Review 4.  The cellular prion protein (PrP(C)): its physiological function and role in disease.

Authors:  Laura Westergard; Heather M Christensen; David A Harris
Journal:  Biochim Biophys Acta       Date:  2007-03-02

5.  New insights into metal interactions with the prion protein: EXAFS analysis and structure calculations of copper binding to a single octarepeat from the prion protein.

Authors:  Alex McDonald; M Jake Pushie; Glenn L Millhauser; Graham N George
Journal:  J Phys Chem B       Date:  2013-10-30       Impact factor: 2.991

6.  Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.

Authors:  Petra Steinacker; Andreas Hawlik; Stefan Lehnert; Olaf Jahn; Stephen Meier; Evamaria Görz; Kerstin E Braunstein; Marija Krzovska; Birgit Schwalenstöcker; Sarah Jesse; Christian Pröpper; Tobias Böckers; Albert Ludolph; Markus Otto
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

7.  Difference in redox behaviors between copper-binding octarepeat and nonoctarepeat sites in prion protein.

Authors:  Norifumi Yamamoto; Kazuo Kuwata
Journal:  J Biol Inorg Chem       Date:  2009-07-08       Impact factor: 3.358

8.  Prion-derived copper-binding peptide fragments catalyze the generation of superoxide anion in the presence of aromatic monoamines.

Authors:  Tomonori Kawano
Journal:  Int J Biol Sci       Date:  2006-11-09       Impact factor: 6.580

9.  Prion Protein Does Not Confer Resistance to Hippocampus-Derived Zpl Cells against the Toxic Effects of Cu2+, Mn2+, Zn2+ and Co2+ Not Supporting a General Protective Role for PrP in Transition Metal Induced Toxicity.

Authors:  Pradeep Kumar Reddy Cingaram; Antal Nyeste; Divya Teja Dondapati; Elfrieda Fodor; Ervin Welker
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

Review 10.  Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Authors:  Marcus W Brazier; Anthony G Wedd; Steven J Collins
Journal:  Antioxidants (Basel)       Date:  2014-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.